Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cell-kill kinetics of several S-phase-specific drugs.

× No keyword cloud information.

10 in total

1. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.

Authors: Xuening Wang; Jonathan S Harrison; George P Studzinski
Journal: J Steroid Biochem Mol Biol Date: 2015-08-28 Impact factor: 4.292

2. Experimental combination chemotherapy with thymidylate synthetase and ribonucleotide reductase inhibitors.

Authors: S Kobayashi; T Hoshino; D V Santi
Journal: Pharm Res Date: 1984-07 Impact factor: 4.200

3. Synchronization of stimulated urothelial proliferation. Experimental models for cell cycle specific testing of bladder carcinogens.

Authors: E Kunze; J Weber; P Gellhar; T Graewe; S Scherber
Journal: J Cancer Res Clin Oncol Date: 1987 Impact factor: 4.553

4. A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.

Authors: M Kim; K B Woo; S Perry
Journal: Ann Biomed Eng Date: 1977-03 Impact factor: 3.934

5. ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.

Authors: Daria Fleyshman; Peter Cheney; Anda Ströse; Shaila Mudambi; Alfiya Safina; Mairead Commane; Andrei Purmal; Kelsey Morgan; Nicholas J Wang; Joe Gray; Paul T Spellman; Natalia Issaeva; Katerina Gurova
Journal: Cell Cycle Date: 2015-12-22 Impact factor: 4.534

Cell-kill kinetics of several S-phase-specific drugs.

1. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.

2. Experimental combination chemotherapy with thymidylate synthetase and ribonucleotide reductase inhibitors.

3. Synchronization of stimulated urothelial proliferation. Experimental models for cell cycle specific testing of bladder carcinogens.

4. A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.

5. ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.

6. Experimental investigations on a sequential combination chemotherapy protocol.

7. Inhibition of Human Cervical Cancer Cell Growth by Ethanolic Extract of Boerhaavia diffusa Linn. (Punarnava) Root.

8. Synchronisation by hydroxyurea does not affect the sensitivity of CEM-C7 lymphoblasts to glucocorticoids.

9. Methotrexate and the need for continued research.

10. Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.